-
CD44-Driven Metabolic Rewiring in IDH-Mutant Leukemia
2026-05-05
This study uncovers how CD44 upregulation in IDH-mutant acute myeloid leukemia (AML) drives a unique metabolic dependency, sustaining NADPH generation for oncometabolite production. Targeting the CD44-mediated pathway presents a new vulnerability, with significant implications for combinatorial strategies in hematologic malignancies harboring IDH mutations.
-
ALDH2 Inhibition Triggers Synthetic Lethality in APC-Deficie
2026-05-04
A recent study demonstrates that inhibiting ALDH2 using disulfiram induces synthetic lethality in APC-deficient colorectal cancer via ROS/ASK1/JNK pathway activation. These findings highlight a genotype-selective vulnerability and suggest new avenues for targeted therapy in APC-mutant colorectal cancer.
-
SERL1–OsALDH2B1 Phosphorylation Drives Alkaline Tolerance in
2026-05-04
This study reveals that the SERL1 kinase phosphorylates and stabilizes OsALDH2B1, enhancing both alkaline tolerance and grain size in rice. The work uncovers a dual-function signaling module, providing a promising genetic target for developing stress-resilient, high-yield rice varieties.
-
A Tunable Human Intestinal Organoid Platform for Stemness an
2026-05-03
This study presents a modular organoid system that overcomes the longstanding challenge of balancing stem cell self-renewal and differentiation in human intestinal organoids. By leveraging small molecule pathway modulators, the authors achieve a scalable, reproducible platform with controllable cellular diversity, enabling robust high-throughput experimental applications.
-
Lysoptosis: Evolutionarily Conserved Cell Death via Serpin L
2026-05-02
This study defines lysoptosis as a distinct, evolutionarily conserved form of lysosome-dependent cell death, primarily regulated by intracellular serpins. The findings clarify the mechanistic separation of lysoptosis from other regulated cell death pathways and underscore the importance of serpin-cathepsin interactions for cellular survival.
-
SGI-1027 and Everolimus Synergy: Apoptosis and Pyroptosis in
2026-05-01
This study identifies SGI-1027 as a methuosis inducer that, in combination with everolimus, promotes apoptosis and GSDME-dependent pyroptosis in renal cell carcinoma by disrupting lysosomal membrane integrity. The findings provide a mechanistic rationale for combination therapy to overcome everolimus resistance in advanced RCC.
-
GLT-1 Upregulation Mitigates TBI via CB1-CREB Pathway Modula
2026-05-01
This study reveals that upregulating GLT-1 expression in mice with traumatic brain injury (TBI) reduces neuronal apoptosis and cognitive dysfunction by inhibiting the CB1-CREB signaling pathway. The findings clarify critical interactions between endocannabinoid signaling, astrocytic glutamate transport, and neuroprotection, highlighting mechanistic targets for TBI intervention.
-
Tirbanibulin Analogs as BoNT/A Inhibitors: Insights from KX2
2026-04-30
The reference study demonstrates that KX2-361, a structural analog of Tirbanibulin (KX2-391 dihydrochloride), inhibits botulinum neurotoxin serotype A (BoNT/A) activity in neuronal models, including both pre- and post-intoxication settings. This work advances the search for small-molecule BoNT/A inhibitors capable of acting within neurons, with implications for therapeutic development against botulism.
-
AmpliFold Strategy Boosts Lateral Flow Assay Sensitivity
2026-04-30
This study introduces the 'AmpliFold' capture-and-release workflow, significantly enhancing lateral flow assay (LFA) sensitivity by decoupling analyte capture from detection. The authors demonstrate that triggered release of analyte complexes enables high-affinity rebinding and up to 16-fold signal improvements, with broad implications for rapid diagnostic design.
-
Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele
2026-04-29
This study introduces a zwitterionic peptide amphiphile that achieves high cancer selectivity by leveraging dual enzyme responsiveness for lysosomal self-assembly in cancer cells. The findings demonstrate a substantial increase in selectivity and therapeutic efficacy, with implications for the design of next-generation peptide-based chemotherapeutics.
-
MEK1/2-ERK1/2 Pathway Drives Lung Hemorrhage in Murine Lupus
2026-04-29
This study demonstrates that activation of the MEK1/2-ERK1/2 signaling axis is central to lung endothelial injury and impaired hemostasis leading to diffuse alveolar hemorrhage (DAH) in a murine lupus model. Pharmacological inhibition of MEK1/2 or ERK1/2, but not related MAPK pathways, effectively prevented DAH, offering mechanistic insight and translational relevance for future therapeutic strategy development.
-
Targeting BCL-XL and MCL-1 in Glioblastoma with BH3-Mimetics
2026-04-28
Koessinger et al. reveal that glioblastoma (GBM) cells exhibit elevated anti-apoptotic BCL-XL and MCL-1 expression, conferring heightened sensitivity to BH3-mimetic inhibitors. Their work demonstrates that sequential targeting of these proteins induces robust tumor apoptosis in preclinical models, advancing our understanding of apoptosis-based strategies for GBM therapy.
-
Octanoic Acid-Enriched Nutrition Modulates IBD via PPARγ/STA
2026-04-28
Xue et al. (2025) demonstrate that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by reshaping intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 axis. Their mechanistic findings highlight metabolic-immune crosstalk as a therapeutic target and provide a validated framework for immunometabolic intervention studies.
-
Targeting Cdc42 to Mitigate Kidney Fibrosis: Mechanistic Adv
2026-04-27
A recent study identifies the small molecule daphnepedunin A (DA) as a direct inhibitor of Cdc42, demonstrating its efficacy in reducing kidney fibrosis by intervening in Cdc42-mediated GSK-3β/β-catenin signaling. These findings position Cdc42 inhibition as a promising therapeutic strategy and offer mechanistic insights relevant for translational kidney disease research.
-
Sodium-Induced Mitochondrial Energy Disruption Drives NECSO
2026-04-27
This study reveals how excessive sodium influx via TRPM4 channels impairs mitochondrial metabolism, leading to necrotic cell death (NECSO). The work clarifies the mechanism linking Na+ overload to energy collapse, with implications for understanding cell death in ischemia and related conditions.